Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Jan 10;11(1):6.
doi: 10.1186/s13756-021-01047-x.

Healthcare institutions' recommendation regarding the use of FFP-2 masks and SARS-CoV-2 seropositivity among healthcare workers: a multicenter longitudinal cohort study

Collaborators, Affiliations
Multicenter Study

Healthcare institutions' recommendation regarding the use of FFP-2 masks and SARS-CoV-2 seropositivity among healthcare workers: a multicenter longitudinal cohort study

Katarzyna Szajek et al. Antimicrob Resist Infect Control. .

Abstract

Background: Health care workers (HCW) are heavily exposed to SARS-CoV-2 from the beginning of the pandemic. We aimed to analyze risk factors for SARS-CoV-2 seroconversion among HCW with a special emphasis on the respective healthcare institutions' recommendation regarding the use of FFP-2 masks.

Methods: We recruited HCW from 13 health care institutions (HCI) with different mask policies (type IIR surgical face masks vs. FFP-2 masks) in Southeastern Switzerland (canton of Grisons). Sera of participants were analyzed for the presence of SARS-CoV-2 antibodies 6 months apart, after the first and during the second pandemic wave using an electro-chemiluminescence immunoassay (ECLIA, Roche Diagnostics). We captured risk factors for SARS-CoV-2 infection by using an online questionnaire at both time points. The effects of individual COVID-19 exposure, regional incidence and FFP-2 mask policy on the probability of seroconversion were evaluated with univariable and multivariable logistic regression.

Results: SARS-CoV-2 antibodies were detected in 99 of 2794 (3.5%) HCW at baseline and in 376 of 2315 (16.2%) participants 6 months later. In multivariable analyses the strongest association for seroconversion was exposure to a household member with known COVID-19 (aOR: 19.82, 95% CI 8.11-48.43, p < 0.001 at baseline and aOR: 8.68, 95% CI 6.13-12.29, p < 0.001 at follow-up). Significant occupational risk factors at baseline included exposure to COVID-19 patients (aOR: 2.79, 95% CI 1.28-6.09, p = 0.010) and to SARS-CoV-2 infected co-workers (aOR: 2.50, 95% CI 1.52-4.12, p < 0.001). At follow up 6 months later, non-occupational exposure to SARS-CoV-2 infected individuals (aOR: 2.54, 95% CI 1.66-3.89 p < 0.001) and the local COVID-19 incidence of the corresponding HCI (aOR: 1.98, 95% CI 1.30-3.02, p = 0.001) were associated with seroconversion. The healthcare institutions' mask policy (surgical masks during usual exposure vs. general use of FFP-2 masks) did not affect seroconversion rates of HCW during the first and the second pandemic wave.

Conclusion: Contact with SARS-CoV-2 infected household members was the most important risk factor for seroconversion among HCW. The strongest occupational risk factor was exposure to COVID-19 patients. During this pandemic, with heavy non-occupational exposure to SARS-CoV-2, the mask policy of HCIs did not affect the seroconversion rate of HCWs.

Keywords: FFP-2 and surgical masks; Healthcare workers; Mask policy; SARS-CoV-2; Seroconversion.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Timeline of the study. The pandemic in the Canton of Grisons from March 2020 to March 2021 is represented by the 7-day running mean of daily numbers of new COVID-19 cases. Horizontal bars indicate the time of baseline and follow up sampling in the participating health care institutions (HCIs)
Fig. 2
Fig. 2
Flow diagram for study participants
Fig. 3
Fig. 3
Risk factors associated with SARS-CoV-2 seroconversion (multivariate model) at baseline. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) as well as p values (Wald tests) derived from a logistic mixed-effects model for seroconversion at baseline (n = 2749)
Fig. 4
Fig. 4
Risk factors associated with SARS-CoV-2 seroconversion (multivariate model) at follow-up. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) as well as p values (Wald tests) derived from a logistic mixed-effects model for seroconversion at survey 2 (n = 2139)

References

    1. Korth J, Wilde B, Dolff S, Frisch J, Jahn M, Krawczyk A, et al. SARS-CoV-2 seroprevalence in healthcare workers in Germany: a follow-up study. Int J Environ Res Public Health. 2021;18(9):4540. doi: 10.3390/ijerph18094540. - DOI - PMC - PubMed
    1. Sikkema RS, Pas SD, Nieuwenhuijse DF, O'Toole Á, Verweij J, van der Linden A, et al. COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study. Lancet Infect Dis. 2020;20(11):1273–1280. doi: 10.1016/S1473-3099(20)30527-2. - DOI - PMC - PubMed
    1. Talbot LR, Romeiser JL, Spitzer ED, Gan TJ, Singh SM, Fries BC, et al. Prevalence of IgM and IgG antibodies to SARS-CoV-2 in health care workers at a tertiary care New York hospital during the Spring COVID-19 surge. Perioper Med (Lond) 2021;10(1):7. doi: 10.1186/s13741-021-00177-5. - DOI - PMC - PubMed
    1. Rashid-Abdi M, Krifors A, Salleber A, Eriksson J, Mansson E. Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study. Infect Dis (Lond) 2021;53(3):169–175. doi: 10.1080/23744235.2020.1849787. - DOI - PubMed
    1. Lidstrom AK, Sund F, Albinsson B, Lindback J, Westman G. Work at inpatient care units is associated with an increased risk of SARS-CoV-2 infection; a cross-sectional study of 8679 healthcare workers in Sweden. Upsala J Med Sci. 2020;125(4):305–310. doi: 10.1080/03009734.2020.1793039. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances